Personalized Algorithm Helps Guide Rituximab Retreatment

(MedPage Today) -- A personalized algorithm was developed by researchers in England to recommend retreatment with rituximab (Rituxan) among patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, with the intention of preventing...